Anlotinib combined with temozolomide suppresses glioblastoma growth via mediation of JAK2/STAT3 signaling pathway

PURPOSE: Anlotinib protects against carcinogenesis through the induction of autophagy and apoptosis. The current study evaluated the role and molecular mechanisms of anlotinib in glioblastoma, and the effects of anlotinib in combination with temozolomide (TMZ). METHODS: Cell Counting Kit-8 and colon...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Peng, Wang, Handong, Pan, Hao, Chen, Jiakai, Deng, Chulei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8807469/
https://www.ncbi.nlm.nih.gov/pubmed/34997858
http://dx.doi.org/10.1007/s00280-021-04380-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8807469/
https://www.ncbi.nlm.nih.gov/pubmed/34997858
http://dx.doi.org/10.1007/s00280-021-04380-5

Ejemplares similares